Vaccines - Brunei Darussalam

Brunei Darussalam

The Vaccines market in Brunei Darussalam is expected to witness a significant increase in revenue.
According to projections, the revenue is estimated to reach US$3.17m in 2024.
Moreover, it is anticipated that the market will experience a steady growth rate of -0.06% annually from 2024 to 2029, resulting in a market volume of US$3.16m by 2029.
In terms of global comparison, it is noteworthy that United States is projected to generate the highest revenue in the Vaccines market.
In 2024, United States is expected to generate a substantial amount of US$29,120.00m.
Brunei Darussalam is making significant strides in the development and distribution of vaccines, establishing itself as a regional leader in healthcare innovation.

Key regions: Australia, Italy, France, South Korea, Brazil

Market

Region

Region comparison

Currency

Analyst Opinion

The demand for vaccines in Brunei Darussalam has been growing steadily over the years, driven by an increasing awareness of the importance of preventive healthcare among the population.

Customer preferences: The majority of the population in Brunei Darussalam prefer vaccines that are safe, effective, and affordable. They also prefer vaccines that offer protection against a wide range of diseases, including seasonal flu, measles, and pneumonia. As a result, there has been a growing demand for combination vaccines that offer protection against multiple diseases.

Trends in the market: One of the key trends in the vaccines market in Brunei Darussalam is the increasing adoption of new and innovative vaccines. In recent years, there has been a growing demand for vaccines that offer better protection against emerging infectious diseases such as COVID-19, dengue fever, and Zika virus. This has led to the development of new vaccines that offer better protection against these diseases.Another trend in the market is the increasing use of technology in vaccine development and distribution. With the rise of digital technologies, vaccine manufacturers are now able to develop and distribute vaccines more efficiently, which has helped to reduce costs and improve access to vaccines.

Local special circumstances: One of the key challenges facing the vaccines market in Brunei Darussalam is the limited availability of vaccines. While the government provides free vaccines to children and certain high-risk groups, there is still a significant proportion of the population that does not have access to vaccines. This is partly due to the high cost of vaccines, which can be a barrier for many people.

Underlying macroeconomic factors: The vaccines market in Brunei Darussalam is heavily influenced by the country's macroeconomic environment. The country has a small and open economy that is heavily dependent on oil and gas exports. This means that any fluctuations in global oil prices can have a significant impact on the country's economic growth and consumer spending.Despite these challenges, the vaccines market in Brunei Darussalam is expected to continue growing in the coming years, driven by an increasing focus on preventive healthcare and the development of new and innovative vaccines. As the government continues to invest in healthcare infrastructure and services, the demand for vaccines is likely to increase further, providing opportunities for vaccine manufacturers and distributors to expand their operations in the country.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.